CV Sciences, Inc.
CVSI
$0.02
$0.008.33%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -17.54% | -11.40% | -14.86% | -15.76% | -8.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.54% | -11.40% | -14.86% | -15.76% | -8.45% |
| Cost of Revenue | -13.57% | -16.17% | -25.87% | -19.65% | -15.19% |
| Gross Profit | -21.37% | -5.79% | -0.36% | -11.19% | -0.86% |
| SG&A Expenses | -9.97% | -12.95% | -15.91% | -17.19% | -1.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.40% | -2.28% | -21.11% | -18.38% | -7.91% |
| Operating Income | -129.77% | -2,990.91% | 81.39% | 40.35% | -10.08% |
| Income Before Tax | -195.02% | -530.39% | 72.43% | 16.23% | 55.31% |
| Income Tax Expenses | -- | -- | 114.29% | -- | -- |
| Earnings from Continuing Operations | -196.93% | -489.91% | 71.63% | 16.23% | 55.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -196.93% | -489.91% | 71.63% | 16.23% | 55.31% |
| EBIT | -129.77% | -2,990.91% | 81.39% | 40.35% | -10.08% |
| EBITDA | -282.19% | -417.20% | 81.31% | 35.79% | -69.77% |
| EPS Basic | -171.43% | -466.67% | 71.79% | 16.00% | 58.82% |
| Normalized Basic EPS | 0.00% | -180.00% | 58.82% | 35.00% | -125.00% |
| EPS Diluted | -171.43% | -466.67% | -79.49% | 16.00% | 58.82% |
| Normalized Diluted EPS | 0.00% | -180.00% | 58.82% | 35.00% | -125.00% |
| Average Basic Shares Outstanding | 11.30% | 1.44% | -0.03% | 1.10% | 6.87% |
| Average Diluted Shares Outstanding | 11.30% | 1.44% | -0.03% | 1.10% | 6.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |